FDA
-
-
-
-
-
-
-
CDT Equity partners with QIMA to test tapinarof drug combinations
-
-
-
-
-
-
-
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
-
-
-
-
-
-
-
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
-
-
-
-
-
-
-
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
-
-
-
-
-
-
-
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
-
-
-
-
-
-
-
CDT Equity files two patents to expand tapinarof intellectual property
-
-
-
-
-
-
-
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
-
334,514 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


